ARTICLE | Tools & Techniques
Imaging immunotherapy
How a new PET agent could predict immunotherapy responses sooner
June 14, 2018 11:27 PM UTC
Stanford University researchers have made an imaging agent that detects activated T cells and could predict whether a patient will respond to immunotherapy within days of treatment.
Typically, it takes weeks to months to determine if a treatment is halting tumor growth. Earlier biomarkers for efficacy could not only streamline clinical trials, but could provide information about the biology of a therapy in patients, and enable physicians to adjust dosing and optimize treatment combinations in real time. ...